Trial intelligence / Profile preview

Naltrexone in Compulsive Sexual Behavior

NCT00467558Phase 2Completed

Sponsor
University of Minnesota
Start
May 2007
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naltrexone in compulsive sexual behavior disorder (CSBD), sponsored by University of Minnesota. Started May 2007; status: completed.

02

Drugs

naltrexone
03

Conditions

compulsive sexual behavior disorder (CSBD)

Beyond the preview

Go deeper on NCT00467558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00467558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call